Director Market Access
Illumina
Director Market Access
Illumina
Develops sequencing platforms and consumables
The Director, Market Access – Commercial Coverage & Reimbursement will lead the company's U.S. commercial payer strategy to expand patient access to genomic sequencing and genetic testing. This individual will develop and execute strategies to achieve favorable coverage, reimbursement, and utilization policies across national and regional commercial health plans. The role requires deep expertise in commercial payer decision-making, evidence generation, reimbursement policy, and provider adoption.
Working cross-functionally with Medical Affairs, Health Economics & Outcomes Research (HEOR), Clinical Affairs, Government Affairs, Commercial, and Legal, this leader will translate clinical and economic evidence into successful market access strategies that improve patient access to genomic sequencing and genetic testing while supporting business growth.
Requirements
Illumina develops and sells integrated sequencing systems and the consumables needed to analyze genetic variation and biological function. Its instruments use sequencing-by-synthesis on flow-cell-based platforms, with specialized reagents and library preparation kits that are consumed per run. The company differentiates itself through a broad end-to-end ecosystem, a large installed base that drives repeat purchases, and strategic acquisitions that expand capabilities into multiomics and clinical applications. Its goal is to advance genomic analysis for research and clinical diagnostics to enable personalized medicine and early cancer detection.
Explore more opportunities at Illumina